SCHEMBL16366342

SCHEMBL16366342

CN[C@@H](C(=O)Nc1cc2c3c(c(-c4cnn(C)c4)[nH]c3c1)C=NNC2=O)C1CCCCC1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.84
PLK4 O00444 2/20 0.84
CHEK2 O96017 2/20 0.84
ABL1 P00519 2/20 0.84
EGFR P00533 2/20 0.84
LCK P06239 2/20 0.84
FYN P06241 2/20 0.84
CDK1 P06493 2/20 0.84
RET P07949 2/20 0.84
FGFR1 P11362 2/20 0.84
SRC P12931 2/20 0.84
FGFR3 P22607 2/20 0.84
RPS6KB1 P23443 2/20 0.84
MARK3 P27448 2/20 0.84
KDR P35968 2/20 0.84
FLT3 P36888 2/20 0.84
LIMK1 P53667 2/20 0.84
BTK Q06187 2/20 0.84
PRKAA1 Q13131 2/20 0.84
MARK2 Q7KZI7 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14502695 0.94 AURKA (0.84) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL16366040 0.92 AURKA (0.83) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL31517136 0.91 AAK1 (1.00) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL13987443 0.91 AAK1 (1.00) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL13599879 0.91 AAK1 (1.00) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL16366082 0.85 AURKA (0.69) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL16366569 0.84 AURKA (0.67) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL14396960 0.83 AURKA (0.75) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL14503108 0.83 AURKA (0.69) AURKAPLK4CHEK2ABL1EGFR
SCHEMBL4808134 0.81 AURKB (0.79) AURKAPLK4CHEK2ABL1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014204856-A1 FATTY ACID ANTICANCER DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2014-12-24 WO disclosed